Aging in place start-up K4Connect has been selected for the National Association of Realtors’ 2021 Tech Accelerator.
North Carolina start-up K4Connect is behind the K4Community solution,...
New Bakar Aging Research Institute aims to drive deeply collaborative research to enhance translational medicine, progressing novel therapies from lab to clinic to community.
UC...
Innovative biotech Juvenescence has announced it has appointed Dr Grazia Piizzi as its Chief Scientific Officer.
Juvenescence Ltd, a life sciences company focused on modifying...
Announcing our new 'jobs in longevity' system and international 'executive search' service.
As many of us enter a long-weekend there'll be some downtime to consider...
From increased risk aversion to changed consumption patterns, CaixaBank Research economist highlights key issues presented by aging.
The world is aging, and aging fast. The...
New funding opportunity for longevity clinical trials from National Institute on Aging emphasises preventing aging and age-related disease.
The NIA, which is part of the...
Professor Mikhail Blagosklonny takes a look at therapeutic research done within the longevity field and concludes that there must be a re-focusing on lifespan...
New economic model estimates that targeting aging has larger economic gains than eradicating individual diseases: time for a policy pivot?
Although life expectancy has increased...
Open Life data project secures funding to help UK develop pandemic resilience and promote healthy life extension.
The All Party-Parliamentary Group (APPG) for Longevity has...
UK business confidence is at six-year high as biotech innovation and vaccine success dispel lockdown gloom.
Data from IHS Markit demonstrates that British business confidence...
Lancet commentary calls for immediate large-scale clinical trials of rapamycin and rapalogs, with geroprotective consequences.
In March last year, as the global coronavirus pandemic took...
Longevity, biotech, investment, sustainability and ethics: Jim Mellon's new book, MOO'S LAW, addresses the opportunities and challenges of our need for protein.
Getting time with...
New funds, switching focus to longevity, Silicon Valley blue-bloods and preparing for IPO.
Over the past year, we’ve had the pleasure of speaking with some...
New economic model estimates that targeting aging has larger economic gains than eradicating individual diseases: time for a policy pivot?
Although life expectancy has increased...
Professor Mikhail Blagosklonny takes a look at therapeutic research done within the longevity field and concludes that there must be a re-focusing on lifespan...
Longevity, biotech, investment, sustainability and ethics: Jim Mellon's new book, MOO'S LAW, addresses the opportunities and challenges of our need for protein.
Getting time with...
Harvard researcher proposes the Daphnia water flea as an alternative to worms for building a scalable platform for antiaging drugs research.
In many ponds and...
Insilico closes $255 million to progress into human clinical trials and develop novel targets and also announces Teva Pharm collaboration.
Insilico Medicine, a company driving...
